0,969  0,001  VCAM1 expression inhibitor
0,964  0,003  Chemoprotective
0,956  0,001  Cholesterol antagonist
0,956  0,002  Chemopreventive
0,951  0,002  Monophenol monooxygenase inhibitor
0,934  0,004  Transcription factor NF kappa B inhibitor
0,919  0,003  Antihypercholesterolemic
0,913  0,002  Proliferative diseases treatment
0,913  0,002  Antihypoxic
0,912  0,002  Antimutagenic
0,888  0,001  Amylase inhibitor
0,868  0,003  Antithrombotic
0,864  0,003  Sensitization
0,864  0,005  Teratogen
0,850  0,004  Mutagenic
0,848  0,006  Embryotoxic
0,847  0,005  Caspase 9 stimulant
0,841  0,002  Xanthine oxidase inhibitor
0,844  0,010  Antiinflammatory
0,828  0,004  Antioxidant
0,813  0,002  Melanin inhibitor
0,816  0,006  Antidiabetic
0,816  0,006  Cyclophilin D inhibitor
0,822  0,014  Apoptosis agonist
0,805  0,004  Vasodilator, coronary
0,802  0,003  Mediator release inhibitor
0,794  0,006  Radioprotector
0,782  0,004  Antibacterial
0,780  0,004  Free radical scavenger
0,773  0,004  Angiogenesis stimulant
0,772  0,004  Cardioprotectant
0,760  0,003  Antiparasitic
0,754  0,004  NOS2 expression inhibitor
0,753  0,004  DNA damaging
0,747  0,003  Antihelmintic
0,732  0,005  Vasodilator, peripheral
0,730  0,005  Hypoglycemic
0,706  0,010  Respiratory analeptic
0,697  0,005  Antiamyloidogenic
0,697  0,005  Antipyretic
0,700  0,011  Carcinogenic
0,687  0,003  Antidote
0,683  0,009  Immunostimulant
0,678  0,004  Antihypertriglyceridemic
0,677  0,005  Apoptosis antagonist
0,674  0,006  Nitric oxide antagonist
0,646  0,009  Cytotoxic
0,652  0,018  Antileukemic
0,637  0,004  Interleukin agonist
0,651  0,018  TNF expression inhibitor
0,669  0,039  Alpha-glucosidase inhibitor
0,637  0,008  Antipruritic, allergic
0,629  0,005  Vascular (periferal) disease treatment
0,611  0,006  UGT1A1 substrate
0,598  0,004  ICAM1 expression inhibitor
0,604  0,013  Stroke treatment
0,595  0,005  Skin whitener
0,596  0,011  Hepatic disorders treatment
0,592  0,008  Antifungal
0,592  0,014  Immunosuppressant
0,591  0,014  Analeptic
0,575  0,008  Antineoplastic (osteosarcoma)
0,598  0,035  Antineoplastic (breast cancer)
0,572  0,014  Cytostatic
0,560  0,003  Carbonic anhydrase XIII inhibitor
0,588  0,032  Antineoplastic (lung cancer)
0,561  0,005  Hepatoprotectant
0,558  0,003  Antifungal enhancer
0,556  0,003  Protein kinase stimulant
0,566  0,013  NOS3 expression inhibitor
0,553  0,004  Interferon gamma antagonist
0,558  0,010  Tumour necrosis factor alpha release inhibitor
0,540  0,005  NOS3 expression enhancer
0,540  0,006  Anesthetic general
0,543  0,010  DNA synthesis inhibitor
0,536  0,005  Platelet adhesion inhibitor
0,542  0,012  Antiprotozoal (Leishmania)
0,561  0,033  CYP3A4 substrate
0,529  0,003  Expectorant
0,539  0,016  AR expression inhibitor
0,544  0,021  Antineoplastic (ovarian cancer)
0,521  0,002  Selectin antagonist
0,528  0,009  Antineoplastic (lymphoma)
0,527  0,017  UGT1A9 substrate
0,525  0,016  Antineoplastic (brain cancer)
0,513  0,006  Septic shock treatment
0,520  0,018  Caspase 3 stimulant
0,509  0,010  UGT2B4 substrate
0,504  0,008  Interleukin 2 agonist
0,512  0,019  Lipoprotein disorders treatment
0,507  0,013  Amyloid beta aggregation inhibitor
0,511  0,022  Immunomodulator
0,491  0,003  Antihelmintic (Nematodes)
0,492  0,005  Alkylator
0,492  0,007  Non-steroidal antiinflammatory agent
0,482  0,003  Antihemorrhagic
0,487  0,013  Vasodilator
0,506  0,035  Antineoplastic (colorectal cancer)
0,473  0,003  Antispirochetal
0,474  0,006  Sulfotransferase substrate
0,486  0,022  Antiischemic
0,479  0,019  Antidiabetic (type 2)
0,495  0,037  CYP2C9 substrate
0,482  0,026  Antineoplastic (melanoma)
0,457  0,004  AMP-activated protein kinase stimulant
0,463  0,014  UDP-glucuronosyltransferase substrate
0,476  0,036  Prostate cancer treatment
0,440  0,004  Carbonic anhydrase VI inhibitor
0,457  0,023  Antineoplastic (multiple myeloma)
0,447  0,014  Myocardial infarction treatment
0,435  0,004  Aldose reductase substrate
0,469  0,038  Antineoplastic (colon cancer)
0,432  0,003  Carbonic anhydrase XIV inhibitor
0,433  0,005  Cell adhesion inhibitor
0,433  0,005  Acute respiratory distress syndrome (ARDS) treatment
0,437  0,011  Antiviral (Herpes)
0,442  0,016  Antineoplastic (endocrine cancer)
0,465  0,043  Histamine release inhibitor
0,436  0,018  Antineoplastic (liver cancer)
0,427  0,008  Lipid peroxidase inhibitor
0,427  0,019  Antineoplastic (renal cancer)
0,434  0,031  Antimycobacterial
0,423  0,021  Radiosensitizer
0,404  0,004  Antineoplastic, alkylator
0,429  0,032  Antineoplastic (pancreatic cancer)
0,428  0,032  Antineoplastic (cervical cancer)
0,418  0,022  Hypolipemic
0,404  0,010  Antiviral (Influenza)
0,397  0,005  Dementia treatment
0,401  0,010  Antipruritic, non-allergic
0,395  0,005  Vascular dementia treatment
0,397  0,007  Peptidyltransferase inhibitor
0,422  0,041  5 Hydroxytryptamine release stimulant
0,380  0,003  Vanilloid 1 agonist
0,390  0,017  Antineoplastic (sarcoma)
0,399  0,033  Antineoplastic (non-small cell lung cancer)
0,371  0,008  Antidiarrheal
0,366  0,007  UDP-glucose 4-epimerase inhibitor
0,431  0,079  Antiarthritic
0,414  0,063  Antiprotozoal
0,371  0,025  Antiulcerative
0,360  0,017  Antihypotensive
0,400  0,059  Ulceration
0,380  0,040  Antineoplastic (glioma)
0,351  0,013  Genotoxic
0,338  0,004  ATPase inhibitor
0,366  0,034  Antineoplastic (glioblastoma multiforme)
0,339  0,007  Cystathionine beta-synthase inhibitor
0,377  0,045  Spasmolytic
0,329  0,008  Antineoplastic antibiotic
0,326  0,006  Antibiotic
0,322  0,005  Beta glucuronidase inhibitor
0,326  0,011  Insulin sensitizer
0,350  0,036  Antidiabetic symptomatic
0,316  0,011  Insulin secretagoues
0,405  0,102  Antineoplastic (solid tumors)
0,320  0,018  Restenosis treatment
0,326  0,024  P-glycoprotein inhibitor
0,329  0,029  Wound healing agent
0,302  0,005  Phosphofructokinase-1 inhibitor
0,298  0,003  Phosphodiesterase 6D inhibitor
0,309  0,017  Topoisomerase II inhibitor
0,304  0,014  Interleukin 6 antagonist
0,300  0,016  Antiviral (Influenza A)
0,327  0,044  Platelet antagonist
0,285  0,006  Antifungal (Cryptococcus)
0,318  0,040  UGT1A6 substrate
0,345  0,073  Angiogenesis inhibitor
0,311  0,040  Antineoplastic (lymphocytic leukemia)
0,283  0,013  Topoisomerase I inhibitor
0,284  0,023  Neurotrophic factor enhancer
0,268  0,007  Beta amyloid protein antagonist
0,314  0,061  CYP2C19 substrate
0,267  0,017  Adenylate cyclase inhibitor
0,255  0,005  Photosensitizer
0,276  0,026  Antineoplastic (squamous cell carcinoma)
0,267  0,020  Hemostatic
0,281  0,034  DNA methylase inhibitor
0,261  0,014  Cell wall synthesis inhibitor
0,277  0,032  Eye irritation, high
0,284  0,040  Antineoplastic enhancer
0,248  0,004  Toll-Like receptor 4 antagonist
0,270  0,026  Antiacne
0,252  0,010  Topoisomerase II alpha inhibitor
0,258  0,016  DNA polymerase I inhibitor
0,273  0,039  RNA-directed DNA polymerase inhibitor
0,242  0,009  Antirickettsial
0,298  0,067  Antituberculosic
0,237  0,006  Transcription factor NF kappa B stimulant
0,239  0,010  Cyclooxygenase 3 inhibitor
0,230  0,006  DNA repair enzyme inhibitor
0,234  0,011  Choleretic
0,266  0,046  Antiviral (HIV)
0,221  0,010  Mucolytic
0,219  0,011  Growth stimulant
0,215  0,009  Cell adhesion molecule inhibitor
0,293  0,087  Antineoplastic (small cell lung cancer)
0,239  0,036  Thrombolytic
0,212  0,009  Chronic obstructive bronchitis treatment
0,203  0,005  Antiviral (Rhinovirus)
0,215  0,017  Microtubule formation inhibitor
0,198  0,005  Protein 50S ribosomal subunit inhibitor
0,198  0,005  Interleukin 12 antagonist
0,214  0,022  Neurotrophic factor
0,202  0,013  Adenylate cyclase stimulant
0,280  0,092  CYP2D6 substrate
0,217  0,029  Antidiabetic (type 1)
0,235  0,048  UGT2B7 substrate
0,216  0,030  Alpha-N-acetylglucosaminidase inhibitor
0,209  0,023  Antinephritic
0,231  0,048  Nitric-oxide synthase stimulant
0,201  0,021  Retinoprotector
0,201  0,022  Interleukin 4 antagonist
0,191  0,012  Antiviral (Influenza B)
0,217  0,038  Liver fibrosis treatment
0,324  0,146  Alzheimer's disease treatment
0,199  0,022  Antibacterial (Helicobacter pylori)
0,173  0,002  Sodium/glucose cotransporter inhibitor
0,173  0,002  Cholesterol absorption inhibitor
0,255  0,084  Huntington's disease treatment
0,204  0,034  Skin irritative effect
0,175  0,006  Phosphorylase inhibitor
0,281  0,112  Antiprotozoal (Plasmodium)
0,205  0,038  Neuropathy treatment
0,190  0,024  Carcinogenic, group 2B
0,249  0,083  Transcription factor STAT3 inhibitor
0,186  0,023  Interleukin 1b antagonist
0,165  0,003  Heparanase inhibitor
0,167  0,005  Antibiotic Glycopeptide-like
0,205  0,045  Protein-tyrosine phosphatase inhibitor
0,203  0,043  Hair growth stimulant
0,162  0,004  Na+ K+ transporting ATPase inhibitor
0,159  0,004  Antimycoplasmal
0,184  0,034  Protein-tyrosine phosphatase 1B inhibitor
0,163  0,014  Thioredoxin inhibitor
0,179  0,031  Glutathione S-transferase substrate
0,160  0,013  HIV-1 integrase (3'-Processing) inhibitor
0,220  0,074  Interleukin antagonist
0,192  0,047  Antineoplastic (carcinoma)
0,204  0,060  Sepsis treatment
0,184  0,040  Antiprotozoal (Coccidial)
0,144  0,001  Sodium/glucose cotransporter 2 inhibitor
0,161  0,023  Ca2+-transporting ATPase inhibitor
0,172  0,036  Antiviral (Hepatitis B)
0,170  0,036  Cholesterol synthesis inhibitor
0,248  0,115  Bone diseases treatment
0,194  0,062  Diabetic nephropathy treatment
0,140  0,009  Antiviral (Dengue virus)
0,140  0,010  ATPase (Vacuolar H+) inhibitor
0,164  0,037  DNA intercalator
0,147  0,021  Alcohol dehydrogenase inhibitor
0,185  0,059  Anticoagulant
0,138  0,014  HIV-1 integrase (Strand Transfer) inhibitor
0,143  0,019  NADH dehydrogenase inhibitor
0,151  0,030  HDL-cholesterol increasing
0,129  0,010  Phosphodiesterase VI inhibitor
0,184  0,065  Antineoplastic (gastric cancer)
0,224  0,107  Antiosteoporotic
0,126  0,013  Aldose reductase inhibitor
0,184  0,071  Myocardial ischemia treatment
0,139  0,028  Uric acid excretion stimulant
0,219  0,113  Transcription factor STAT inhibitor
0,114  0,009  Antitreponemal
0,128  0,023  Antiviral (Trachoma)
0,174  0,070  Antineoplastic (bone cancer)
0,130  0,028  Actinic keratosis treatment
0,258  0,157  Atherosclerosis treatment
0,129  0,028  Triose-phosphate isomerase inhibitor
0,106  0,005  Glucose-6-phosphate translocase inhibitor
0,104  0,006  Alpha-mannosidase inhibitor
0,115  0,019  Interferon agonist
0,128  0,035  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,130  0,038  Carbonic anhydrase III inhibitor
0,096  0,003  Antibiotic Aminoglycoside-like
0,220  0,129  CYP1A2 substrate
0,096  0,006  Mannosidase inhibitor
0,148  0,059  Interleukin 1 antagonist
0,093  0,004  Arginase inhibitor
0,109  0,025  Vanilloid agonist
0,097  0,014  Interferon inducer
0,084  0,003  Sodium/glucose cotransporter 1 inhibitor
0,099  0,019  Prostaglandin EP2 antagonist
0,104  0,025  Thioredoxin reductase inhibitor
0,153  0,078  Carcinogenic, group 1
0,078  0,004  Protein 30S ribosomal subunit inhibitor
0,088  0,015  Nitric oxide donor
0,127  0,055  Alcohol dehydrogenase substrate
0,086  0,014  Factor IXa inhibitor
0,080  0,009  Adenine nucleotide translocase inhibitor
0,079  0,009  Glucose-6-phosphate isomerase inhibitor
0,247  0,177  Antineoplastic (myeloid leukemia)
0,097  0,027  HIV-1 integrase inhibitor
0,251  0,183  Antiparkinsonian
0,096  0,029  Lipase inhibitor
0,158  0,092  Phospholipase C inhibitor
0,119  0,056  Aldehyde dehydrogenase substrate
0,094  0,032  Histone deacetylase SIRT1 stimulant
0,094  0,032  Histone deacetylase stimulant
0,122  0,064  Antineoplastic antimetabolite
0,074  0,018  Leukotriene B4 antagonist
0,115  0,059  Chelator
0,080  0,025  Carbonic anhydrase XII inhibitor
0,085  0,033  Prokinetic
0,125  0,073  Antineoplastic (uterine cancer)
0,077  0,026  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,110  0,059  Gout treatment
0,138  0,089  Phospholipase A2 inhibitor
0,096  0,049  Carcinogenic, group 2A
0,075  0,029  Neuraminidase (influenza) inhibitor
0,077  0,032  Gaucher disease treatment
0,061  0,017  Factor III inhibitor
0,063  0,020  Antiviral (Herpesvirus 3, Human)
0,061  0,018  Equilibrative nucleoside transport protein inhibitor
0,121  0,079  Cyclooxygenase 1 inhibitor
0,045  0,003  Vanilloid 2 agonist
0,136  0,095  UGT1A3 substrate
0,141  0,102  Muscular dystrophy treatment
0,097  0,063  UGT2B11 substrate
0,036  0,003  Antibiotic Anthracycline-like
0,038  0,005  Toll-Like receptor 4 agonist
0,059  0,026  Antimetabolite
0,054  0,022  Microtubule stabilization
0,109  0,077  Estrogen antagonist
0,091  0,060  Glutamate release inhibitor
0,073  0,046  Peroxisome proliferator-activated receptor gamma agonist
0,033  0,008  1,3-Beta-glucan synthase inhibitor
0,080  0,056  Glycine receptor antagonist
0,031  0,009  Motilin receptor agonist
0,027  0,005  Antibiotic Macrolide-like
0,141  0,120  UGT2B10 substrate
0,119  0,099  Psychosexual dysfunction treatment
0,049  0,029  Carbonic anhydrase VII inhibitor
0,024  0,005  Telomerase stimulant
0,061  0,042  Neuraminidase inhibitor
0,131  0,114  Uterine stimulant
0,066  0,053  Andropause treatment
0,061  0,049  CDC25B inhibitor
0,052  0,041  Maillard reaction inhibitor
0,056  0,045  Lipocortins synthesis agonist
0,046  0,038  Estrogen agonist
0,090  0,082  Antifungal (Candida)
0,097  0,090  Antitussive
0,059  0,052  Leukotriene antagonist
0,127  0,123  Cystic fibrosis treatment
0,021  0,017  GRP78 expression inhibitor
0,032  0,029  HMG CoA reductase inhibitor
0,067  0,067  GABA aminotransferase inhibitor

